NCT06150534View on ClinicalTrials.gov

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

December 27, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Primary Immunodeficiency Diseases (PID)
Interventions
OTHER

No Intervention

This is a non-interventional study.

Trial Locations (1)

27709

Research Triangle Park, Raleigh

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY